Ronald Stafford Watts
Director/Board Member at Wenkart Foundation
Ronald Stafford Watts active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Wenkart Foundation | Director/Board Member | - | - |
Biosceptre International Ltd.
 Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Director/Board Member | - | - |
Career history of Ronald Stafford Watts
Former positions of Ronald Stafford Watts
| Companies | Position | Start | End |
|---|---|---|---|
| ENERGY ACTION LIMITED | Director/Board Member | 2015-11-11 | 2017-06-29 |
| Chairman | 2011-10-13 | 2015-11-11 | |
Biosceptre (Aust) Pty Ltd.
 Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Director/Board Member | - | - |
Training of Ronald Stafford Watts
| University of Cambridge | Doctorate Degree |
| The University of New South Wales | Undergraduate Degree |
Statistics
International
| Australia | 5 |
| United Kingdom | 3 |
Operational
| Director/Board Member | 4 |
| Chairman | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ENERGY ACTION LIMITED | Commercial Services |
| Private companies | 3 |
|---|---|
Biosceptre (Aust) Pty Ltd.
Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Health Technology |
| Wenkart Foundation | |
Biosceptre International Ltd.
Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Health Technology |
